how do you get glp-1 Weight Loss Options GLP-1 Agonists - What is
Description
The 2023 New England Journal of Medicine publication described a randomized, double-blind, placebo-controlled Phase 2 trial in adults with obesity or overweight with at least one related condition
doi: 10.1016/j.ejphar.2012.12.012 [DOI] [PubMed] [Google Scholar] 132
This medication is truly unique because it acts as a dual agonist, meaning it targets two different hormone receptors in your body: Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP)
He carefully listens to concerns and offers treatment option that best fit the patient
Serious risks include low blood sugar, dehydration with low blood pressure, ketoacidosis, kidney infections, and serious genital infections, especially when Jardiance is combined with insulin, diuretics, sulfonylureas, or glinides
2012;142:S821
